@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-X2025J48-F
  skos:prefLabel "Adrenergic beta-2 Receptor Agonists"@en, "Agonistes des récepteurs béta-2 adrénergiques"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-LFSSXL9R-K
  skos:prefLabel "Xinafoate de salmétérol"@fr, "Salmeterol Xinafoate"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-WLZ19B75-L .

jvr:-K217ZHRH-X
  skos:prefLabel "Tocolytiques"@fr, "Tocolytic Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-B5GSCCTW-B
  skos:prefLabel "Fumarate de formotérol"@fr, "Formoterol Fumarate"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-WLZ19B75-L .

jvr:-FH8C43MZ-4
  skos:prefLabel "Phénéthylamines"@fr, "Phenethylamines"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-WLZ19B75-L .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-KD3ZGZ4K-4
  skos:prefLabel "Bronchodilator Agents"@en, "Bronchodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CNWWD153-5
  skos:prefLabel "Lévosalbutamol"@fr, "Levalbuterol"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-WLZ19B75-L .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-SNFL356D-X
  skos:prefLabel "Ethanolamines"@en, "Éthanolamines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-WLZ19B75-L .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-HFWV2449-0
  skos:prefLabel "Association de bromure d'ipratropium et de salbutamol"@fr, "Albuterol, Ipratropium Drug Combination"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-WLZ19B75-L .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WLZ19B75-L
  mesh:allowableQualifier jvr:-NHL3D2X0-S, jvr:-SBNWSM1T-R, jvr:-HQRFT0C6-B, jvr:-XV06LPML-W, jvr:-S0CS1X5R-5, jvr:-M63HSDM7-1, jvr:-G4R176S9-J, jvr:-CB30NGKB-3, jvr:-W6SQV79N-S, jvr:-BT300B3G-Q, jvr:-Q3979798-W, jvr:-NB0XHT3S-N, jvr:-H7K65Q8S-Z, jvr:-THHNVC7V-3, jvr:-TJHVZCRZ-0, jvr:-L6C0XPHT-4, jvr:-NKM836P1-M, jvr:-R3QWLHRG-V, jvr:-D0F21513-5, jvr:-WK5F724J-1, jvr:-FWD2BGQ0-9, jvr:-T9HQD7ST-J, jvr:-G30ZJ446-J, jvr:-R0ZCQ8X6-J, jvr:-NFTHND7Q-8 ;
  skos:hiddenLabel "Albutérol sulfate"@fr, "Albuterol Sulfate"@en, "Ventoline"@fr, "Sultanol"@fr, "Sultanol"@en, "Sulfate de salbutamol"@fr, "Salbutamol sulfate"@fr, "Ventolin"@en, "Sulfate d'albutérol"@fr, "Proventil"@en, "Proventil"@fr ;
  skos:narrower jvr:-HFWV2449-0, jvr:-LFSSXL9R-K, jvr:-CNWWD153-5 ;
  skos:altLabel "2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxyméthyl)phényléthanol"@fr, "2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol"@en, "Salbutamol"@en, "18559-94-9 (Albuterol)"@fr, "18559-94-9 (Albuterol)"@en, "51022-70-9 (Albuterol Sulfate)"@en, "51022-70-9 (Albuterol Sulfate)"@fr, "021SEF3731"@fr, "021SEF3731"@en, "Albutérol"@fr, "1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-"@fr, "1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-"@en, "QF8SVZ843E"@fr, "QF8SVZ843E"@en ;
  dc:created "1999-01-01"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-K217ZHRH-X, jvr:-X2025J48-F, jvr:-KD3ZGZ4K-4 ;
  skos:definition "A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol."@en ;
  skos:prefLabel "Albuterol"@en, "Salbutamol"@fr ;
  skos:related jvr:-B5GSCCTW-B ;
  dc:established "1974-01-01"^^xsd:date ;
  skos:inScheme jvr: ;
  skos:broader jvr:-FH8C43MZ-4, jvr:-SNFL356D-X ;
  a skos:Concept, mesh:Descriptor ;
  dc:modified "2015-05-26"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D000420> .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .